As we track these and other developments, here are 10 facts to keep in mind about Ebola and experimental drugs: 1. Some promising Ebola drugs, like Tekmira's TKM-Ebola, have been developed and tested as "post-exposure prophylaxis. There are several experimental drugs in development, with the potential to be useful against Ebola. Ebola is a rare disease, almost completely confined to poor countries -- so funding for drug development has come largely from government agencies in the United States and Canada. On Wednesday, an Iowa-based company called NewLink said it has enough doses of an experimental Ebola vaccine to begin clinical trials in the next few weeks, if such trials are approved.